Vertex files FDA approval ask for next-gen cystic fibrosis candidate, resumes diabetes cell...

[cafead]

via Vertex Pharmaceuticals is ahead of schedule, filing a new drug application for its next-gen cystic fibrosis (CF) treatment dubbed vanza triple.

Vertex completed the regulatory submission a month before its goal of mid-2024, CEO Reshma Kewalramani, M.D., said on a first-quarter earnings call May 6.

article source